29582-31-8

Basic information

• Product Name: (4-ETHOXYBENZOYL)-3-ACRYLIC ACID
• Synonyms: TRANS-(4-ETHOXYBENZOYL)-3-ACRYLIC ACID;3-(4-ETHOXYBENZOYL)ACRYLIC ACID;(4-ETHOXYBENZOYL)-3-ACRYLIC ACID;3-(4-Ethoxybenzoyl)acrylic acid 98%;trans-3-(4-ethoxybenzoyl)acrylic acid;trans-(4-Ethoxybenzoyl)-3-acrylic acid,98%;(E)-4-(4-ethoxyphenyl)-4-oxobut-2-enoic acid;3-(4-Ethoxybenzoyl)acrylicacid98%
• CAS NO: 29582-31-8
• Molecular Formula: C₁₂H₁₂O₄
• Molecular Weight: 220.22
• Product Categories: Aromatic Cinnamic Acids, Esters and Derivatives
• Mol File: 29582-31-8.mol
• Article Data: 1

Chemical Properties

• Melting Point: 140-144 °C
• Boiling Point: 398.2 °C at 760 mmHg
• Flash Point: 155.2 °C
• Appearance: yellow crystalline powder
• Density: 1.205 g/cm³
• Vapor Pressure: 4.68E-07mmHg at 25°C
• CAS DataBase Reference: (4-ETHOXYBENZOYL)-3-ACRYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: (4-ETHOXYBENZOYL)-3-ACRYLIC ACID(29582-31-8)
• EPA Substance Registry System: (4-ETHOXYBENZOYL)-3-ACRYLIC ACID(29582-31-8)

Safety Data

• Hazard Codes: Xn,Xi
• Statements: 36/37/38-22
• Safety Statements: 37/39-26
• Hazardous Substances Data: 29582-31-8(Hazardous Substances Data)

Usage

Chemical Properties

yellow crystalline powder

InChI:InChI=1/C12H12O4/c1-2-16-10-5-3-9(4-6-10)11(13)7-8-12(14)15/h3-8H,2H2,1H3,(H,14,15)/p-1/b8-7+

Upstream product

• 7647-01-0 hydrogenchloride 
• 36680-28-1 (Z)-3-(ethoxycarbonyl)propenoyl chloride 
• 103-73-1 Phenetole 
• 108-31-6 maleic anhydride 

Downstream Products

• 78860-78-3 4-(4-Ethoxy-phenyl)-2-(1H-indol-3-yl)-4-oxo-butyric acid 
• 78860-81-8 2-(1,2-Dimethyl-1H-indol-3-yl)-4-(4-ethoxy-phenyl)-4-oxo-butyric acid 
• 78860-92-1 6-(4-Ethoxy-phenyl)-4-(6-methoxy-1H-indol-3-yl)-4,5-dihydro-2H-pyridazin-3-one 
• 78860-89-6 4-(1,2-Dimethyl-1H-indol-3-yl)-6-(4-ethoxy-phenyl)-4,5-dihydro-2H-pyridazin-3-one 
• 135128-73-3 N-[6-(4-Ethoxy-phenyl)-4-(5-{N'-[1-(4-methoxy-phenyl)-meth-(E)-ylidene]-hydrazino}-3-methyl-1-phenyl-1H-pyrazol-4-yl)-4,5-dihydro-pyridazin-3-yl]-N'-[1-(4-methoxy-phenyl)-meth-(E)-ylidene]-hydrazine 
• 135128-74-4 N-[6-(4-Ethoxy-phenyl)-4-(3-methyl-1-phenyl-5-{N'-[1-p-tolyl-meth-(E)-ylidene]-hydrazino}-1H-pyrazol-4-yl)-4,5-dihydro-pyridazin-3-yl]-N'-[1-p-tolyl-meth-(E)-ylidene]-hydrazine 
• 135128-72-2 N-[6-(4-Ethoxy-phenyl)-4-(3-methyl-1-phenyl-5-{N'-[1-phenyl-meth-(E)-ylidene]-hydrazino}-1H-pyrazol-4-yl)-4,5-dihydro-pyridazin-3-yl]-N'-[1-phenyl-meth-(E)-ylidene]-hydrazine 
• 135128-65-3 6-(4-Ethoxy-phenyl)-5-(4-methoxy-benzyl)-4-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)-2H-pyridazin-3-one 
• 135128-67-5 6-(4-Ethoxy-phenyl)-8-(6-methyl-4-phenyl-4H-pyrazolo[3,4-d][1,2,3]triazol-6a-yl)-7,8-dihydro-tetrazolo[1,5-b]pyridazine 
• 135128-64-2 [3-(4-Ethoxy-phenyl)-5-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)-6-oxo-5,6-dihydro-4H-pyridazin-1-yl]-acetic acid ethyl ester 
• 135128-71-1 [6-(4-Ethoxy-phenyl)-4-(5-hydrazino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-4,5-dihydro-pyridazin-3-yl]-hydrazine 
• 135128-70-0 6-(4-Ethoxy-phenyl)-3-methoxy-4-(5-methoxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-4,5-dihydro-pyridazine 
• 135128-63-1 6-(4-Ethoxy-phenyl)-2-ethyl-4-(3-methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)-4,5-dihydro-2H-pyridazin-3-one 

Relevant articles and documents

Application of 4-oxo-2-crotonamide derivative to preparation of bacteriostatic agents

The invention discloses application of a 4-oxo-2-crotonamide derivative to preparation of bacteriostatic agents. The structure of the 4-oxo-2-crotonamide derivative is shown as a formula (I). The 4-oxo-2-crotonamide derivative has a bacteriostatic effect; good antibacterial activity can be realized on methicillin-resistant staphylococcus aureus, methicillin-resistant staphylococcus epidermidis, vancomycin drug-resistant enterococcus faecalis, vancomycin drug-resistant enterococcus faecium, methicillin-sensitive staphylococcus aureus, methicillin-sensitive staphylococcus epidermidis, vancomycin-sensitive enterococcus faecalis and vancomycin-sensitive enterococcus faecium. The formula I is shown in the description.